7061 - 7070 of 7916 Results
Title
Year
- Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and Signaling2013OPENTitle: Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and SignalingJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 289Issue #: 6Start Page: 3736End Page: 3748Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m113.520981Best OA location URL: http://www.jbc.org/article/S0021925819747607/pdfCitation Count: 32
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study2013OPENTitle: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-xBest OA location URL: https://europepmc.org/articles/pmc4643396?pdf=renderCitation Count: 600
- Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-32013OPENTitle: Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1312701111Best OA location URL: https://www.pnas.org/content/pnas/111/1/E34.full.pdfCitation Count: 107
-
OPENTitle: Parkinson’s disease: what role do pedunculopontine cholinergic neurons play?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 9Issue #: 1Start Page: 5End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.61Best OA location URL: https://europepmc.org/articles/pmc5568855?pdf=renderCitation Count: 6
- Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates2013OPENTitle: Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem CorrelatesJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 73Issue #: 1Start Page: 72End Page: 80Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/nen.0000000000000028Best OA location URL: https://academic.oup.com/jnen/article-pdf/73/1/72/9563424/73-1-72.pdfCitation Count: 39
-
OPENTitle: Atypical presentation of late‐onset Tay‐sachs diseaseJournal Name: Muscle & NervePublisher: WileyVol: 49Issue #: 5Start Page: 768End Page: 771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mus.24146Best OA location URL: https://europepmc.org/articles/pmc4346308?pdf=renderCitation Count: 33
-
OPENTitle: Pure hereditary spastic paraplegia due to a de novo mutation in the NIPA1 geneJournal Name: European Journal of NeurologyPublisher: WileyVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.12284Best OA location URL: https://europepmc.org/articles/pmc4138605?pdf=renderCitation Count: 9
-
OPENTitle: Parkinson's Disease Biomarkers: Resources for Discovery and ValidationJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 1Start Page: 241End Page: 242Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2013.246Best OA location URL: https://www.nature.com/articles/npp2013246.pdfCitation Count: 6
-
OPENTitle: Gait impairment precedes clinical symptoms in spinocerebellar ataxia type 6Journal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 2Start Page: 252End Page: 255Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25706Best OA location URL: https://europepmc.org/articles/pmc6551218?pdf=renderCitation Count: 56
-
OPENTitle: Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesiaJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 77Issue #: 4Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neures.2013.10.002Citation Count: 44